Literature DB >> 15153656

Mechanism of action by which aspirin alleviates detrusor hyperactivity in rats.

Yasuhiro Tsukimi1, Kaori Mizuyachi, Hiroko Matsumoto, Masako Sato, Betty Ng, Masaomi Tajimi.   

Abstract

We examined the effect of aspirin on urodynamic parameters in normal and cyclophosphamide-induced cystitic rats and compared them in rats with or without sensory denervation. Cystometry was performed under urethane anesthesia; and volume threshold for micturition (VT), micturition frequency (MF), micturition pressure (MP), and micturition volume (MV) were determined. Cystitis was induced by pretreatment with cyclophosphamide and sensory denervation was performed by pretreating animals with a large dose of capsaicin. PGE(2) and 6-keto-PGF(1alpha) contents in the bladder were determined by ELISA. Sensory intact, cystitic rats showed decrement of VT and increment of MF. Aspirin increased VT and decreased MF in the cystitic condition. Both PGE(2) and 6-keto-PGF(1alpha) contents in the bladder were significantly increased in cystitic rats, but such increases were completely inhibited by aspirin. In sensory denervated rats, aspirin showed a marginal tendency of increment of VT. Cystitic rats showed overflow micturition in the sensory denervated condition, but VT was the same as that of normal rats. Furthermore, following capsaicin pretreatment, aspirin had no effect on the cystometrogram in cystitic rats. From these findings, it is concluded that suppression of sensory C-fiber via inhibition of PGs synthesis in the bladder is involved in the pharmacological action of aspirin in the detrusor hyperactivity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15153656     DOI: 10.1254/jphs.95.101

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  4 in total

Review 1.  Emerging pharmacological targets in overactive bladder therapy: experimental and clinical evidences.

Authors:  Emilio Sacco; Francesco Pinto; Pierfrancesco Bassi
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-01-15

2.  New insights into molecular targets for urinary incontinence.

Authors:  Manoj K Poonia; Ginpreet Kaur; Meena Chintamaneni; Ilesh Changela
Journal:  Indian J Pharmacol       Date:  2010-10       Impact factor: 1.200

3.  Therapeutic effects of the putative P2X3/P2X2/3 antagonist A-317491 on cyclophosphamide-induced cystitis in rats.

Authors:  Katsuaki Ito; Akihito Iwami; Hiromi Katsura; Masahiro Ikeda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-10-05       Impact factor: 3.000

4.  Effect of co-administration of BRL-37344 and tadalafil on reduction of overactive bladder symptoms after induction of detrusor overactivity in mice1.

Authors:  Marcos Fiuza de Carvalho; Thuliermes Lopes Pamplona; Márcio Alencar Barreira; Francisco Vagnaldo Jacuru Fechine; Lúcio Flávio Gonzaga-Silva; Ricardo Reges Maia de Oliveira
Journal:  Acta Cir Bras       Date:  2019-02-28       Impact factor: 1.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.